The results showed that the following factors could partly explain the heterogeneity but did not reach statistical significance: patient origin ( I 2 =85.68%; adjusted R 2 =16.54%; P =0.06), cancer type ( I 2 =83.65%; adjusted R 2 =10.95%; P =0.59), and multivariate analysis ( I 2 =86.84%, adjusted R 2 =−8.60%; P =0.97).
← all excerpts
Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis.
1
0.0600
0.0600